Global MicroRNA Reverse Transcription Market, By Products Type (Instruments, Kits & reagents, Consumables), By Services Type (Sample Collection, Whole Blood, Plasma, Serum, Others), By Methods (Quantitative PCR, In-Situ Hybridization, Microarrays, RNA-Sequencing, Others), By Application (Cancer, Kidney disease, Neurological disease, Cardiovascular disease, Others), By End User (Academic and Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Diagnostic Centers) and opportunities and forecast 2020-2027
MicroRNA Reverse Transcription Market Overview
MicroRNAs (miRNAs) are a class of non-coding RNAs that play important roles in regulating gene expression. MicroRNA are abundantly found in the mammalian types and target approximately 60% of the genes of the human and other mammals. The global MicroRNA Reverse Transcription market is projected to show significant growth in the forecast period. A single miRNA can target hundreds of mRNAs and influence the expression of many genes. Further, miRNA reverse transcription is involved in many allergies’ diseases such as eosinophilic esophagitis, asthma, and many others. This factor is expected to increase the demand for MicroRNA Reverse Transcription, which in turn is enhancing their market statistics.
Furthermore, increasing incidence of cancer, neurological disorder, and others are projected to boost the growth of the MicroRNA reverse transcription market. In addition to this, MicroRNA reverse transcriptase is found to be associated with the immune system, cancer stem cells, and androgen receptor expression properties in triple-negative breast cancer. According to World Health Organization, as of the end of 2020, there were 7.8 million women alive who were diagnosed with breast cancer in the past 5 years, making it the world’s most prevalent cancer.
However, accurate delivery of these molecules to an intracellular site such as nucleus and cytosol and also limited research infrastructure in emerging markets are anticipated to hamper the growth of the MicroRNA reverse transcriptase market.
Covid-19 Impact on MicroRNA Reverse Transcription Market:
In addition, the current MicroRNA Reverse Transcription Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the MicroRNA Reverse Transcription Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Based on the products type, the Kits & reagents segment has significant growth in the market. There are various kits available such as the TaqMan, MicroRNA reverse transcriptase is specifically designed to generate specific cDNA, for the use with the TaqMan MicroRNA Assays is also anticipated to increase the growth of the MicroRNA reverse transcriptase market in the forthcoming years. Additionally, increasing development in genomics technologies and computational approaches are further propelling the development of the market in the next few years. Also, therapeutics demonstration in preclinical studies using these molecules is estimated to increase the R&D investment in the coming years.
MicroRNA Reverse Transcription Market, By Products Type
· Instruments · Kits & reagents · Consumables
MicroRNA Reverse Transcription Market, By Services Type
MicroRNA Reverse Transcription Market, By End User
· Academic and Research Institutes · Biopharmaceutical Companies · Contract Research Organizations · Diagnostic Centers
MicroRNA Reverse Transcription Regional Overview
Region-wise, North America is projected to account for the largest share of the global MicroRNA Reverse Transcription market. This can be mainly attributed to the well-established healthcare infrastructure, rising R&D activities in the healthcare sector, and tremendous development in the technology in this region. In addition to this, the US is the major market for MicroRNA Reverse Transcription owing to the presence of several key market players. Similarly, the market in Asia-Pacific is expected to witness significant growth during the forecast period. This is due to the increasing healthcare expenditure and emerging healthcare infrastructure in this region.
MicroRNA Reverse Transcription Market, By Geography
· North America (US & Canada) · Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe) · Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific) · LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
· Sigma Aldrich Corp. · Thermo Fisher Scientific, Inc. · Agilent Technologies · Illumina, Inc. · Bio-Rad Laboratories Inc. · System Biosciences LLC · HTG Molecular Diagnostics, Inc. · GeneCopoeia, Inc. · New England Biolabs, Inc.